Dirican, Abuzer; Unal, Bulent; Bassulu, Nuray; Ozgor, Dincer; Kayaalp, Cuneyt; Yilmaz, Sezai
July 2010
Pakistan Journal of Medical Sciences;Jul2010, Vol. 26 Issue 3, p733
Academic Journal
Case Study
Liver and other solid organ transplant recipients are at an increased risk of developing several malignancies because of the immuno-suppressive treatment. Generally, patients who had a liver transplant have upper gastrointestinal tract complaints, which makes identification of gastric carcinoma symptoms in those patients difficult. A 58 years old liver transplant male patient presented to the hospital for his routine checkup and dyspeptic complaints. He had received a liver from a cadaver 18 months ago and his postoperative period had been uneventful. An esophagogastroduodenoscopy (EGD) revealed gastric cancer. A subtotal gastric resection with a D2 lymph node dissection was carried out. There was no recurrence during three years follow up. In order to make a timely identification of the occurrence of common malignancies such as gastric cancer, liver transplant recipients must be followed closely.


Related Articles

  • Microvascular free-flap transfer for head and neck reconstruction in elderly patients. Turrà, Francesco; La Padula, Simone; Razzano, Sergio; Bonavolontà, Paola; Nele, Gisella; Marlino, Sergio; Canta, Luigi; Graziano, Pasquale; Orabona, Giovanni Dell'Aversana; Schonau, Fabrizio // BMC Surgery;2013, Vol. 13 Issue Suppl 2, p1 

    Background: With the increase in life expectancy, the incidence of head and neck cancer has grown in the elderly population. Free tissue transfer has become the first choice, among all the reconstructive techniques, in these cases. The safety and success of micro vascular transfer have been well...

  • Free Tissue Transfer in the Head and Neck Cancer Patient with Graft-versus-Host Disease. Lin, Samuel J.; Frankenthaler, Robert // Journal of Otolaryngology -- Head & Neck Surgery;Apr2009, Vol. 38 Issue 2, pE42 

    The article presents a case study relating to the free tissue transfer of the head and neck of a patient with cancer and graft-versus-host disease. Topics discussed in the article include microvascular changes that exist in patients with graft-versus-host disease and microvascular free tissue...

  • Cancers cutanés après transplantation : quoi de neuf ? Euvrard, S.; Kanitakis, J. // Oncologie;Feb2013, Vol. 15 Issue 2, p106 

    Skin cancers are the commonest cancers after organ transplantation, affecting in the long term 60-75% of the patients. They include mostly carcinomas, especially squamous and basal cell carcinomas, but also melanoma, Kaposi's sarcoma and other rare skin tumours such as Merkel cell carcinoma. The...

  • In Brief.  // Urology Times;1/1/2006, Vol. 34 Issue 1, p3 

    The article presents news briefs related to urology and cancer treatment. Researchers at the University of North Carolina at Chapel Hill have found a distinct interaction between the phosphorylation activity of AckI and Wwox degradation, suggesting AckI as a target for future cancer therapy....

  • Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation. Smitz, J.; Dolmans, M. M.; Donnez, J.; Fortune, J. E.; Hovatta, O.; Jewgenow, K.; Picton, H. M.; Plancha, C.; Shea, L. D.; Stouffer, R. L.; Telfer, E. E.; Woodruff, T. K.; Zelinski, M. B. // Human Reproduction Update;Jul2010, Vol. 16 Issue 4, p395 

    BACKGROUND: Female cancer patients are offered ‘banking’ of gametes before starting fertility-threatening cancer therapy. Transplants of fresh and frozen ovarian tissue between healthy fertile and infertile women have demonstrated the utility of the tissue banked for restoration of...

  • O6-benzylguanine-mediated enhancement of nitrosourea activity in Mer- central nervous system tumor xenografts--implications for clinical trials. Keir, Stephen T.; Dolan, M. Eileen; Pegg, Anthony E.; Lawless, Amy; Moschel, Robert C.; Bigner, Darell D.; Friedman, Henry S.; Keir, S T; Dolan, M E; Pegg, A E; Lawless, A; Moschel, R C; Bigner, D D; Friedman, H S // Cancer Chemotherapy & Pharmacology;Jun2000, Vol. 45 Issue 6, p437 

    Purpose: To evaluate the role of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) plus O6-benzylguanine (O6-BG) in the treatment of both Mer+ and Mer- tumors.Methods: The effect of pretreatment with O6-BG on the activity of BCNU against Mer- human central nervous tumor...

  • PREVENTION OF MUCOSITIS IN AUTO BMT/STEM CELL TRANSPLANT PATIENTS. Klocke, Joan; Cannon, Maureen; Gissinger, Diane; Bayer, Ruthee; Devoe, Craig; John, Veena // Oncology Nursing Forum;Mar2006, Vol. 33 Issue 2, p454 

    t is estimated that 80 percent of patients who undergo high-dose chemotherapy prior to transplantation develop mucositis. Mucositis is a painful complication, which can lead to poor nutrition, increased use of narcotics, dehydration, greater risk for infection and bacteremia and altered quality...

  • Kidney Transplants for Cancer Patients.  // Medical Update;2003, Vol. 29 Issue 6, p8 

    Addresses a question on the possibility of kidney transplant to a colon cancer patient.

  • Annexin V-TRAIL fusion protein is a more sensitive and potent apoptotic inducer for cancer therapy. Fan Qiu; Minjin Hu; Bo Tang; Xiufeng Liu; Hongqin Zhuang; Jie Yang; Zi-Chun Hua // Scientific Reports;12/20/2013, p1 

    The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising cancer therapeutic agent, which kills cancer cells selectively, while leaving normal cells unharmed. However, the emerging resistance of tumor cells and patients to TRAIL-induced apoptosis limits its further...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics